News

Public · Published

37 Capital Announces Proposed Repricing of Insider Stock Options

37 Capital's board approved a proposed reduction in the exercise price, the amount insiders pay to buy shares, for 2,865,000 insider-held options, from prices of $0.10 to $0.155 per share to $0.05. The repricing is not final and requires Canadian Securities Exchange and disinterested shareholder approval, which the company plans to seek at its December 18, 2026 meeting.

Published:

Updated:

What happened

37 Capital’s board approved a proposed reduction in the exercise price, the amount insiders pay to buy shares, for 2,865,000 insider-held options, from prices of $0.10 to $0.155 per share to $0.05. The repricing is not final and requires Canadian Securities Exchange and disinterested shareholder approval, which the company plans to seek at its December 18, 2026 meeting.

Proposed

Global impact / market context

If approved, insiders could buy shares through these options at a lower price, reducing the cost of exercising them. That may affect how insiders choose to exercise or hold their options, while leaving the stated expiry dates and vesting schedules unchanged; the article provides no financial impact estimate.

Analyst inference

This is a proposed change to existing insider compensation, not a completed issuance of shares. Approval depends on both the Canadian Securities Exchange and shareholders without an interest in the repricing, so the lower exercise price cannot yet be treated as final.

Confirmed

What to watch

  1. The company says it intends to seek disinterested shareholder approval at its annual general and special meeting scheduled for December 18, 2026. Confirmed
  2. The Canadian Securities Exchange must approve the repricing; until that decision and shareholder approval are received, the proposed $0.05 exercise price remains conditional. Confirmed
  3. If both approvals are secured, compare later company disclosures on option exercises and share issuance to assess whether the repricing changes the number of shares held by insiders. Analyst inference

Evidence